Oral Session 2-7B PTCL/NK lymphoma: Treatment (1)

[OS2-7B-4] A phase II study of THP-COP in newly diagnosed advanced peripheral T-cell lymphoma: THP-3 study

Michinori Ogura^1,2, Ken Ohmachi³, Ritsuro Suzuki⁴, Yoshiko Atsuta⁵, Tatsuya Ito⁶, Kazuma Ohyashiki⁷, Shingo Yano⁸, Michihiro Hidaka⁹, Kiyoshi Ando³, Noriko Fukuhara¹⁰, Yoshihisa Morishita¹¹, Takayo Suzuki¹², Kunihiro Tsukasaki¹³, Naoki Kobayashi¹⁴, Norifumi Tsukamoto¹⁵, Yukiyasu Ozawa¹⁶, Kazuhito Yamamoto¹⁷, Tomomitsu Hotta¹⁸, Tomohiro Kinoshita¹⁷ (1.Hematology/Oncology, Kasugai Municipal Hospital, Kasugai, Japan, 2.Hematology/Oncology, Nagoya Daini Red Cross Hospital, Nagoya, Japan, 3.Hematology/Oncology.,Tokai Univ.,Isehara,Japan, 4.HSCT Data Manage. & Biostat., Nagoya Univ., Nagoya, Japan, 5.Japanese Data Center for Hematopoietic Cell Transplantation (JDCHCT), Nagoya, Japan, 6.Div. Hematol. & Oncol., Anjyo Kosei Hospital, Anjo, Japan, 7.Hematol. Tokyo Med. Univ., Tokyo, Japan, 8.Clin. Oncol. and Hematol., Jikei Univ., Tokyo, Japan, 9.Hematol., NHO KMC, Kumamoto, Japan, 10.Dept. Hematol. Rheumatol., Tohoku Univ., Sendai, Japan, 11.Hematol & Oncol, Konan Kosei Hospital, Konan, Japan, 12.Hematol & Oncol., Shiga Medical Center for Adults, Moriyama, Japan, 13.Hematol., Nagasaki University, Nagasaki, Japan, 14.Hematol., Sapporo Hokuyu Hospital, Sapporo, Japan, 15.Hematol, Gunma Univ, Gunma, Japan, 16.Hematol., JRC Nagoya Daiichi Hosp., Nagoya, Japan, 17.Dept Hematol Cell Therapy, Aichi Cancer Ctr, Nagoya, Japan, 18.National Cancer Center, Tokyo, Japan)